BioVaxys Technology's total assets for Q3 2025 were C$1.39M, an increase of 26.02% from the previous quarter. TSE:BIOV total liabilities were C$5.03M for the fiscal quarter, a 31.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.